GIUSTI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 6.492
EU - Europa 4.635
AS - Asia 2.526
SA - Sud America 336
Continente sconosciuto - Info sul continente non disponibili 74
AF - Africa 69
OC - Oceania 41
Totale 14.173
Nazione #
US - Stati Uniti d'America 6.398
PL - Polonia 1.596
RU - Federazione Russa 1.198
IT - Italia 782
SG - Singapore 725
CN - Cina 578
HK - Hong Kong 420
VN - Vietnam 311
BR - Brasile 271
SE - Svezia 246
IE - Irlanda 236
KR - Corea 184
FI - Finlandia 127
FR - Francia 126
DE - Germania 121
GB - Regno Unito 78
IN - India 76
CA - Canada 48
AU - Australia 38
JP - Giappone 38
ID - Indonesia 37
JO - Giordania 34
AR - Argentina 29
BE - Belgio 26
BD - Bangladesh 25
NL - Olanda 19
TR - Turchia 19
CI - Costa d'Avorio 18
IQ - Iraq 17
UA - Ucraina 17
ES - Italia 15
CH - Svizzera 12
MX - Messico 12
PK - Pakistan 12
ZA - Sudafrica 12
CO - Colombia 11
DO - Repubblica Dominicana 8
JM - Giamaica 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
DZ - Algeria 7
EC - Ecuador 7
NG - Nigeria 7
RO - Romania 7
MA - Marocco 6
CL - Cile 5
CZ - Repubblica Ceca 5
IL - Israele 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
LT - Lituania 4
LV - Lettonia 4
PY - Paraguay 4
SV - El Salvador 4
AZ - Azerbaigian 3
HN - Honduras 3
HU - Ungheria 3
KZ - Kazakistan 3
MY - Malesia 3
NI - Nicaragua 3
VE - Venezuela 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
CG - Congo 2
EU - Europa 2
HR - Croazia 2
IR - Iran 2
KW - Kuwait 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
SC - Seychelles 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AI - Anguilla 1
AO - Angola 1
AT - Austria 1
BJ - Benin 1
ET - Etiopia 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
SI - Slovenia 1
Totale 14.097
Città #
Warsaw 1.593
Santa Clara 1.226
Ashburn 829
Fairfield 536
Singapore 480
Hong Kong 363
Chandler 287
San Jose 266
Woodbridge 243
Dublin 236
Seattle 226
Cambridge 217
Houston 204
Seoul 179
Beijing 172
Ann Arbor 169
Wilmington 168
Council Bluffs 113
Milan 104
Ho Chi Minh City 103
Lawrence 84
Altamura 79
Los Angeles 74
Florence 72
Princeton 70
Hefei 67
Buffalo 66
Lauterbourg 63
Munich 63
Hanoi 60
The Dalles 58
Rome 55
Helsinki 54
Boston 53
New York 49
Shanghai 43
Dallas 40
Phoenix 38
Melbourne 36
Mumbai 34
Boardman 33
Medford 32
San Diego 31
São Paulo 31
Tokyo 29
Jakarta 28
Naples 28
Paris 27
Chicago 26
Turin 25
Dong Ket 24
Moscow 23
Brussels 22
Clifton 22
Turku 22
Abidjan 18
Kent 18
Pune 16
Redondo Beach 16
Palermo 15
Andover 13
Da Nang 13
Haiphong 13
Jacksonville 13
Norwalk 13
Orem 13
Bern 12
Falls Church 12
Rio de Janeiro 12
Bologna 11
Brooklyn 11
Denver 11
Frankfurt am Main 11
Lappeenranta 10
London 10
Yubileyny 10
Atlanta 9
Bari 9
North Bergen 9
Washington 9
Izmir 8
Miami 8
Montreal 8
Philadelphia 8
Renton 8
Toronto 8
Brescia 7
Figino 7
Johannesburg 7
Lyon 7
Manchester 7
Stockholm 7
Abuja 6
Baghdad 6
Bengaluru 6
Charlotte 6
Columbus 6
Durham 6
Hillsboro 6
Newark 6
Totale 9.720
Nome #
Natural History of MEN1 GEP-NET: Single-Center Experience After a Long Follow-Up. 356
Management impact: effects on quality of life and prognosis in MEN1 349
Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database 344
Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens 334
MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors 332
The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the "Knudson's second hit". 325
Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign. 318
Correction to: Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database. 315
Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology 314
Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update 284
Calcium Intake in Bone Health: A Focus on Calcium-Rich Mineral Waters 281
Thyroid cancer: current molecular perspectives. 280
A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. 276
The LARO-MEN1 study: a longitudinal clinical experience with octreotide Long-Acting Release in patients with Multiple Endocrine Neoplasia type 1 Syndrome 271
Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity. 251
When Parathyroidectomy Should Be Indicated or Postponed in Adolescents With MEN1-Related Primary Hyperparathyroidism 245
Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients 223
Blomstrand’s chondrodysplasia 222
A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome. 220
Total and Subtotal Parathyroidectomy in Young Patients With Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism: Potential Post-surgical Benefits and Complications 220
Calcifediol: mechanisms of action 218
Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database 218
Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report. 213
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease. 202
Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. 199
DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes 198
Hereditary hyperparathyroidism syndromes. 195
Circulating MicroRNAs as Biomarkers of Osteoporosis and Fragility Fractures 194
CYP19 and ESR1 gene polymorphisms: response of the bone mineral density in post-menopausal women to hormonal replacement therapy 193
Calcolosi renale recidivante: una nnuova mutazione del gene codificante il recettore del calcio( CASR) 190
Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization. 189
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1) 187
Genetic predictors of skeletal outcomes in healthy fertile women: The Bonturno Study. 183
Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors. 183
Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs 180
Carcinoma mammario e osteoporosi: risultati preliminari di uno studio fiorentino 179
Sarcomatoid carcinoma of the kidney in a MEN1 patient: Case report and genetic profile. 176
Genetic test in multiple endocrine neoplasia type 1 syndrome: An evolving story. 175
Osteonecrosis of the jaw in a patient with rheumatoid artritis treated with an oral aminobisphosphonate: a clinical case report. 174
Prevalence of Osteoporosis and Risk Factors For Bone Demineralization In Italy: First Results From the Firmo Study 174
Haplotype analysis of two pairs of unrelated Italian families affected by Paget's disease of bone, exhibiting different geographical origins and two different mutations of p62/sequestosomel gene, supports the evidence for common founders. 173
Osteonecrosis of the Jaw In A Patient With Rheumatoid Artritis Treated With An Oral Aminobisphosphonate: A Clinical Case Report 171
Variazioni molecolari del gene codificante la fosfatasi alcalina: correlazione con la massa ossea (BMD) e i markers biochimici di turnover osseo 171
Endocrine sequelae of hematopoietic stem cell transplantation: Effects on mineral homeostasis and bone metabolism 170
Soft tissue postraumatic calcifications associated with a new FGF23 gene mutation: clinicopathological and molecular genetic study 165
Calcifediol: Why, When, How Much? 164
Un particolare caso di iperparatiroidismo primitivo giovanile 162
[Left laparoscopic adrenalectomy for pheochromocytoma in MEN 2B: case report]. 161
Molecular diagnosis of parathyroid carcinoma: a reality in the near future. 160
Un nuovo caso di sclerosi ossea: osteopochilosi 157
ALPL genotypes in patients with atypical femur fractures or other biochemical and clinical signs of hypophosphatasia 157
A New Fgf23 Gene Polymorphism: Possible Role In the Pathogenesis of the Development of Extraskeletal Calcifications? 154
Association of vitamin D and bisphenol A levels with cardiovascular risk in an elderly Italian population: results from the InCHIANTI study 153
Fracture unit: a (possible) model of implementation in Italy. 151
Association between vitamin D and bisphenol A levels in an elderly Italian population: results from the InCHIANTI study 151
Genetic Determinants of inherited endocrine tumors: do they have a direct role in bone metabolism regulation and osteoporosis? 148
Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens: response to comments by Chen et al. 148
Efficacy of Cinacalcet Therapy In Patients Affected By Primary Hyperparathyroidism Associated To Multiple Endocrine Neoplasia Syndrome Type 1 (men1): Preliminary Results of the Florentine Study 145
Genotype-Phenotype Correlation Analyses in an Italian MEN1 Series. MEN1 Gene Mutational Performed at the Center for Hereditary Endocrine Tumors of Florence 143
Prevalenza dell'osteoporosi e dei principale fattori di rischio nella popolazione italiana: risultiati del BOne tour 2012 136
Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 136
THE EFFECTS OF RH-PTH (1-34) ON BONE METABOLISM IN HYPOPARATHYROID PATIENTS 136
Tricho-rhino-phalangeal syndrome: role of different methods of measuring bone density 133
High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fracture 132
Pancreatic neuroendocrine tumors in MEN1 patients: difference in post-operative complications and tumor progression between major and minimal pancreatic surgeries 130
A NOVEL TISSUE-NONSPECIFIC ISOENZYME OF ALKALINE PHOSPHATASE (TNSALP) MUTATION IN ADULT PATIENT WITH LOW BONE MASS AND MUSCULOSKELETAL SYMPTOMS 128
CALCIFICATIONS IN DERMATOMYOSITIS: A CLINICAL CASE WITH AN ALTERATION OF PHOSPHATE HOMEOSTASIS, CARRIER OF A NEW FGF23 GENE MUTATION 123
Osteogenesis Imperfecta: Realization of A Multidisciplinar Network To Improve Information, Expertise and Resources 117
Multiple Endocrine Neoplasia Type 1 115
Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery? 111
RETROSPECTIVE COHORT STUDY OF PATIENTS AFFECTED BY CHRONIC HYPOPARATHYROIDISM 85
Serums miR-24-3p and miR-1301-3p as potential biomarkers in MEN1 syndrome 57
Evolving our understanding of vitamin D, periostin levels and cardiovascular risk in the elderly: a cross sectional study 30
Osteopetrosis: Pathogenesis, Clinical Management, and Emerging Therapies 20
Totale 14.173
Categoria #
all - tutte 37.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.447


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022367 0 0 0 21 23 15 21 38 18 28 74 129
2022/20231.178 117 265 39 86 83 200 140 58 134 11 23 22
2023/2024574 12 50 80 22 23 81 35 216 10 14 21 10
2024/20253.490 124 347 239 529 1.107 417 48 217 162 57 132 111
2025/20263.753 459 499 282 306 394 160 483 180 194 271 80 445
2026/2027759 146 124 323 166 0 0 0 0 0 0 0 0
Totale 14.173